Merck's Phase III and II FSH-CTP trial

The Merck & Co. (Schering-Plough) Phase III press release and the Phase II FSH-CTP clinical trial paper that was published in The Journal of Clinical Endrocrinology and Metabolism are available below:

	July 8, 2008 : Schering-Plough Announces Phase III Data For   Sustained Follicle Stimulant
	Induction of multiple follicular development by a single dose long-acting   recombinant follicle-stimulating hormone (FSH-CTP, Corifollitropin Alfa)   for controlled ovarian stimulation before in vitro fertilization   P. Devroey et al., The Journal of Clinical Endrocrinology and   Metabolism, 89(5): 2062-70 (2004)

 



In order to view a PDF file, you will need the Adobe® Acrobat® Reader^TM, a plug-in available from Adobe Systems, Inc. Please click the below to obtain and install a copy of the plug-in.